Tuckson takes director post

Robeznieks, Andis
October 2011
Modern Healthcare;10/3/2011, Vol. 41 Issue 40, p16
Trade Publication
The article announces the appointment of Doctor Reed Tuckson, chief of medical affairs at Minnesota-based insurer, Minnetonka, to the board of directors for Cell Therapeutics, a Seattle, Washington-based manufacturer of oncology products.


Related Articles

  • Top-notch science op. Rollins, Gina // Modern Physician;Sep2002, Vol. 6 Issue 9, p22 

    Discusses the rewards and opportunities provided by the pharmaceutical industry to physician executives in the U.S. Main appeals of the industry to physicians; Perception on the industry; Qualities and skills that are important to physician executives in the pharmaceutical industry.

  • Physician Executives as Opinion Leaders in Biotechnology and Pharmaceuticals. Tan, Robert S. // Physician Executive;May/Jun2003, Vol. 29 Issue 3, p26 

    Discusses skills that a physician executive needs in order to become an advisor to biotechnology and pharmaceutical industries. Minimum benchmark of certification in clinical specialty; Advice customers about the product; Types of customers seeking opinions from physician executives.

  • Seeking expert advice. Conn, Joseph // Modern Healthcare;5/14/2012, Vol. 42 Issue 20, p18 

    The article announces that C. Martin Harris, Kevin Fickenscher and Russell Branzell were named to the boards of GetWellNetwork, Intelligent InSites and Thermo Fisher Scientific, respectively.

  • RESPONSE. Mathieson, Clive; Cresswell, Adam // BMJ: British Medical Journal (Overseas & Retired Doctors Edition;12/3/2011, Vol. 343 Issue 7834, p1151 

    A response by Adam Cresswell to a letter to the editor regarding the publication of the Health of the Nation series in the newspaper "The Australian," which was sponsored by Medicines Australia, is presented.

  • Medicines agency must tighten COI rules for accounts to be approved. Watson, Rory // BMJ: British Medical Journal (Overseas & Retired Doctors Edition;5/26/2012, Vol. 344 Issue 7858, p6 

    The article reports on the refusal of the European parliament to sign off the financial accounts of the European Medicines Agency for 2010 until the organisation shows that it has effective procedures in place for handling potential conflicts of interest (COI) among its scientific experts.

  • The Tripartite Relationship of Insurance Defense Counsel. McLain, J. Anthony // Alabama Lawyer;Mar2013, Vol. 74 Issue 2, p138 

    The article provides an answer to a question related to conflict of interest between insurance companies.

  • Executives.  // Best's Review;Sep2002, Vol. 103 Issue 5, p10 

    Presents news briefs pertaining to executives of different insurance companies and pharmaceutical industry. Vice president of pharmaceutical services of PacifiCare Health Systems Inc.; Senior vice president and chief investment officer of Allstate Corp.; Executive vice president and chief...

  • Show them the money. Walker, Tracey // Managed Healthcare Executive;Sep2002, Vol. 12 Issue 9, p12 

    Discusses the compensation packages for top talents in managed care/insurance companies in the U.S. Reason for the giving attractive compensation package; Increase in the demand for physician executives with clinical and administrative expertise; Amount of the bonuses and base compensation.

  • Experience, know-how could benefit Cosgrove. Robeznieks, Andis // Modern Healthcare;6/9/2014, Vol. 44 Issue 23, p11 

    The article reflects on the achievements of Cleveland Clinic's, a non-profit academic medical center in Cleveland, Ohio, president and chief executive officer (CEO) Toby Cosgrove who may be nominated by U.S. President Barack Obama to head the U.S. Veterans Affairs Department.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics